Alabama CRS

Alabama CRS
BBRB 256
845 19th Street, S.
Birmingham AL 35294

Faye Heard

fhoward@uabmc.edu

(205)996-4405

Michael Saag

msaag@uab.edu

205-934-7349

• A5357: A Study of Long-Acting Cabotegravir Plus VRC01LS to Maintain Viral Suppression in HIV-1-Infected Adults
• A5366: Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation with Histone Deacetylase Inhibitors
• A5361s: Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
• A5332: REPRIEVE Trial
• A5322: Long-Term Follow-up of Older HIV-infected Adults in the ACTG: Addressing Issues of Aging, HIV Infection and Inflammation (HAILO)
• A5401: ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies
• A5371: A Single-Arm, Open-Label, Pilot Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome with Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)
• A5379: B-Enhancement of HBV vaccination in persons living with HIV (BEe-HIVe): Evaluation of HEPLISAV-B
• A5391: Doravirine for Persons with Excessive Weight Gain on Integrase Inhibitors and Tenofovir Alafenamide (The Do IT Study)
• A5359: The LATITUDE Study